1 |
STUDY |
GE-79 |
GE-79 |
study number |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
COMPLETED VISITS STATUS |
COMPLETED |
COMPLETED |
completed study status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 |
GROUP |
Diabetes |
Control |
group diabetic or non diabetic (control) |
diabetes/control |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
Age |
65 |
78 |
age |
years |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
Age Range |
|
75-79 |
age range |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 |
HEIGHT (M) |
1.7 |
1.5 |
height |
m |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 |
MASS (KG) |
76.7 |
44.0 |
mass |
kg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 |
BMI |
26.6 |
18.5 |
body mass index |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 |
Gender |
M |
F |
sex f-female, M-male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 |
Ethnicity |
Non-H/L |
Non-H/L |
ethnicity non-hispanic/latino ( non-H/L), hispaic -latino ( H/L), |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11 |
Race |
White |
White |
white, african american, asian |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12 |
Hip |
101.5 |
88.3 |
Hip measurements |
cm |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13 |
Iliac Waist |
98 |
76.6 |
Waist measurements |
cm |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14 |
BODY COMPOSITION |
27.3 |
18.9 |
% body fat |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15 |
PREVIOUS TOBACCO USE |
YES |
NO |
PREVIOUS TOBACCO USE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16 |
CURRENT TOBACCO USE |
NO |
NO |
CURRENT TOBACCO USE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17 |
PackYears |
60 |
N/A |
cigarretes packs * years |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
Years |
30 |
N/A |
years of smoking |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19 |
PREVIOUS ALCOHOL USE |
YES |
YES |
PREVIOUS ALCOHOL USE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20 |
CURRENT ALCOHOL USE |
yes |
YES |
Current alcohol use |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21 |
ALCOHOL Dose/Week |
0.14 |
0 |
ALCOHOL Dose/Week |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22 |
Neuropathy AUTONOMIC SYMPTOMS |
YES |
NO |
Neuropathy AUTONOMIC SYMPTOMS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23 |
Dizziness AUTONOMIC SYMPTOMS |
YES |
NO |
Dizziness AUTONOMIC SYMPTOMS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24 |
Numbness AUTONOMIC SYMPTOMS |
YES |
NO |
Numbness AUTONOMIC SYMPTOMS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25 |
Painful feet AUTONOMIC SYMPTOMS |
YES |
NO |
Painful feet AUTONOMIC SYMPTOMS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26 |
Syncope AUTONOMIC SYMPTOMS |
NO |
NO |
Syncope AUTONOMIC SYMPTOMS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27 |
OH AUTONOMIC SYMPTOMS |
NO |
NO |
OH AUTONOMIC SYMPTOMS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28 |
cancer,# FAMILY HISTORY |
1 |
1 |
# number of family members with history of cancer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29 |
cancSpec FAMILY HISTORY |
SISTER |
f |
which family member |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30 |
HeartDisease FAMILY HISTORY |
0 |
1 |
# number of family members with history heart disease |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31 |
HDspecific FAMILY HISTORY |
0 |
0 |
# number of family members with HD, specific gp/grandparent, m/f |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32 |
HTN FAMILY HISTORY |
1 |
1 |
# number of family members with history of hypertension |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33 |
HTNspecific FAMILY HISTORY |
son |
m |
see above |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34 |
DM FAMILY HISTORY |
1 |
0 |
see above |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35 |
Dmspecific FAMILY HISTORY |
sister |
0 |
diabetesmellitus family history |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36 |
StrokeFAMILY HISTORY |
0 |
0 |
StrokeFAMILY HISTORY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
37 |
StrokeSpecific FAMILY HISTORY |
0 |
0 |
StrokeSpecific FAMILY HISTORY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
38 |
HTN PATIENT MEDICAL HISTORY |
NO |
NO |
YES/NO |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
39 |
HTN YRS PATIENT MEDICAL HISTORY |
N/A |
0 |
patientspecific-duration of hypertension |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40 |
CANCER PATIENT MEDICAL HISTORY |
NO |
NO |
CANCER PATIENT MEDICAL HISTORY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41 |
STROKE PATIENT MEDICAL HISTORY |
NO |
NO |
STROKE PATIENT MEDICAL HISTORY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
42 |
STROKE YR PATIENT MEDICAL HISTORY |
n/a |
N/A |
STROKE YR PATIENT MEDICAL HISTORY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43 |
ATRIAL FIBTRILLATION PATIENT MEDICAL HISTORY |
NO |
NO |
ATRIAL FIBTRILLATION PATIENT MEDICAL HISTORY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
44 |
HEART FAILURE =CHF /IFARCTION=-MI PATIENT MEDICAL HISTORY |
MI 1994, CHEST PAIN 2010 |
NO |
HEART FAILURE =CHF /INFARCTION=-MI PATIENT MEDICAL HISTORY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45 |
HYPERLIPIDEMIA PATIENT MEDICAL HISTORY |
YES |
No |
HYPERLIPIDEMIA PATIENT MEDICAL HISTORY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
46 |
DM PATIENT MEDICAL HISTORY |
yes |
NO |
DM PATIENT MEDICAL HISTORY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
47 |
DM YEARS |
8 |
N/A |
# OF YEARS WITH DM |
years |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
48 |
OTHER |
RHEUMATOID ARTHIRITIS, CABG, RAYNAUD'S SYNDROME |
Mitral Valve Prolapse; cataracts |
other illnesses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
49 |
Medications |
Avandia (4 mg), Enbrel (50 mg), Etodolac (300 mg), Lopressor-Metoprolol (50 mg), Methotrexate (2.5 mg), Pravastatin-Sodium (80 mg), Ranitidine (150 mg), Zetia (10 mg) |
Calcium; Vitamin D
|
medications patient takes with dose |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50 |
ANTIPLATELETS |
N |
N |
medication classess subject takes: antiplatelets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
51 |
ANTICOAGULANTS |
N |
N |
medication classess subject takes: Anticoagulants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
52 |
ANTIHYPERLIPIDEMIC |
YES |
N |
medication classess subject takes: Antihyperlipidemic |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53 |
ANTIPARKINSONIAN |
N |
N |
medication classess subject takes: Antiparkinsonian |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
54 |
STATINS |
YES |
N |
medication classess subject takes: Statins |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
55 |
ESTROGEN |
N |
N |
medication classess |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
56 |
ACE INHIBITORS |
N |
N |
medication classess subject takes: Angiotension converting enzyme inhibitors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
57 |
ARBS |
N |
N |
medication classess subject takes: Angiotensin Receptor Blockers |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
58 |
BETA BLOCKERS |
YES |
N |
medication classess subject takes: Beta Blockers |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59 |
DIURETICS |
N |
N |
medication classess subject takes: Diuretics |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60 |
CA ++ BLOCKERS |
N |
N |
medication classess subject takes: Calcium Channel Blockers |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
61 |
INSULIN(Yes_or_No) |
N |
N |
medication classess subject takes: Insulin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
62 |
ORAL HYPOGLYCEMIC |
YES |
N |
medication classess subject takes: Oral hypoglycemics |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
63 |
OTHER |
YES |
YES |
OTHER MEDICATIONS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
64 |
WBC K/uL |
3.7 |
5 |
white blood cells count |
K/uL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
65 |
RBC m/Ul |
3.66 |
4.16 |
red blood cells count |
m/uL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
66 |
Hgb g/dL |
12.1 |
13.8 |
hemoglobin |
g/dL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
67 |
Hct % |
34.2 |
40.7 |
hematocrit |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
68 |
MCV fL |
94 |
98 |
mean corpuscular volume |
pg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69 |
MCH pg |
33.1 |
33.1 |
mean corpuscular volume |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70 |
MCHC % |
35.4 |
33.9 |
mean corpuscular hemoglobin concentration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
71 |
RDW% |
14.6 |
13.8 |
red blood cells dsitribution width |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
72 |
Plt ct K/uL |
93 |
131 |
platelet count |
K/uL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
73 |
GLUCOSE mg/dL |
98 |
75 |
serum glucose |
mg/dL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
74 |
HbA1c |
6.3 |
5.4 |
glycated hemoglobin |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
75 |
TEMP |
97.6 |
96.8 |
temperature |
degrees F |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
76 |
RR |
24 |
18 |
respiratory rate |
breaths/minute |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
77 |
SYSTOLIC BP SITTING BASELINE |
129 |
124 |
baseline systolic blood pressure |
mmhg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
78 |
SYSTOLIC BP STANDING 1 MINUTE |
131 |
106 |
systolic blood pressure standing (1 min) |
mmhg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
79 |
SYSTOLIC BP STANDING 3 MINUTES |
127 |
113 |
systolic blood pressure standing (3 min) |
mmhg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
80 |
SYSTOLIC BP STANDING 5 MINUTES |
126 |
104 |
systolic blood pressure standing (5 min) |
mmhg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
81 |
DIASTOLIC BP SITTING BASELINE |
60 |
60 |
baseline diastolic blood pressure |
mmhg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
82 |
DIASTOLIC BP STANDING 1 MINUTE |
73 |
60 |
diastolic blood pressure standing (1 min) |
mmhg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
83 |
DIASTOLIC BP STANDING 3 MINUTE |
68 |
60 |
diastolic blood pressure standing (3 min) |
mmhg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
84 |
DIASTOLIC BP STANDING 5 MINUTE |
72 |
57 |
diastolic blood pressure standing (5 min) |
mmhg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
85 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
86 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
87 |
CHOLESTmg/dL |
114 |
145 |
cholesterol |
mg/dL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
88 |
TRIGLYCmg/dL |
116 |
85 |
triglyceride |
mg/dL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
89 |
HDL mg/dL |
40 |
55 |
high density cholesterol |
mg/dL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
90 |
CHOL/HD Ratio |
2.85 |
2.63 |
cholesterol/high density cholesterol ratio |
ratio |
average values over the baseline period |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
91 |
VLDLcalc |
23 |
17 |
very low density lipid |
mg/dL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
92 |
LDL CALCmg/dL |
51 |
73 |
low density cholesterol |
mg/dL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
93 |
CREATININE |
110.2 |
57.1 |
creatinine |
mg/dL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
94 |
Microalbumin |
1.9 |
10.5 |
microalbumin |
ug/mL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95 |
Microalb/Creat Ratio |
1.7 |
18.4 |
microalbumin over creatinine ration |
mg/g creat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96 |
C-RP Cardiac |
0.45 |
N/A |
C- reactive protein cardiac |
mg/L |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97 |
GLUC |
99 |
83 |
serum glucose |
mg/dL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98 |
TCD STUDY SUPINE DONE |
yes |
yes |
transcranial doppler study while supine done |
yes/no |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99 |
TCD STUDY SUPINE PROCESSED |
no |
no |
transcranial doppler study while supine processed |
yes/no |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100 |
TCD STUDY SUPINE PROBLEMS |
no |
no |
tcd doppler study during supine problems |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|